Mirae Asset Capital Life Science

About Mirae Asset Capital Life Science

Mirae Asset Capital Life Science is the U.S. affiliate of Mirae Asset Financial Group, dedicated to life science investment. We invest in companies prioritizing the delivery of safe and effective treatments for patients who need them most and believe that superior returns will follow. Our strategy is rooted in core principles that include delivering near-term value, calculated risk, finding innovative yet validated modalities, and rigorous evaluation using our unique backgrounds that span biomedical research, drug discovery, company building, clinical/medical training, and venture capital experience. Mirae Asset Capital Life Science spans the major hubs of life science innovation domestically. Our investment team is located in Boston and San Francisco, and our legal and administrative teams are based in New York.
People
  • David Paik, Senior Vice President